Living Kidney Donor
9
0
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (9)
The Effect of Quadratus Lumborum (QL) Block on the Incidence of Chronic Neuropathic Pain After Retroperitoneal Laparoscopic Donor Nephrectomy: A Study on Neuroinflammation and Neurophysiology
Long-Term Risk of Kidney Stones in Living Kidney Donors
Long-Term Risk of Gout in Living Kidney Donors
Long-term Risk of Cardiovascular Disease in Living Kidney Donors
Fracture Risk in Living Kidney Donors
Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation
Dietary Sodium Intake and Blood Pressure in Living Kidney Donors
Hydrocelectomies in Male Donors
Treg Therapy in Subclinical Inflammation in Kidney Transplantation